Violet Therapeutics Analysis: $11M Raised
What is Violet Therapeutics?
EphB3 inhibitors for neurodegenerative diseases
Location
Cambridge, United States
Employees
1-10
Founded
2021
Product Features & Capabilities
- EphB3 small molecule inhibitor
- C-to-C Engine for cell interaction identification
